Pulmatrix-Eos Merger to Create Controlled Company with Majority Voting Power

Key Facts

1One holder is expected to control over 50% of voting power after the proposed merger between Pulmatrix and Eos SENOLYTIX.

2The merger is contingent on Eos securing at least $13 million in financing and obtaining necessary stockholder approvals.

One holder is expected to control over 50% of voting power following the proposed merger between Pulmatrix, Inc. and Eos SENOLYTIX Inc. Stock Titan reported that the completion of the transaction is contingent on Eos securing at least $13 million in financing and obtaining the necessary approvals from Pulmatrix stockholders.

PULM closed at $1.61 on September 25, 2026, trading between a day low of $1.6 and a high of $1.7 during that session. Under the merger terms, SENOTHERAPEUTIX, Inc. will hold the majority voting stake in the combined entity, which aims to consolidate financial and operational resources as a controlled company under Nasdaq rules.